Cargando…

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia

BACKGROUND: We aimed at identifying variables predicting hypoglycemia in elderly type 2 diabetic patients and the relation to HbA1c values achieved. DESIGN: Prospective, observational registry in 3810 patients in primary care. Comparison of patients in different age tertiles: with an age < 60 (yo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bramlage, Peter, Gitt, Anselm K, Binz, Christiane, Krekler, Michael, Deeg, Evelin, Tschöpe, Diethelm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508810/ https://www.ncbi.nlm.nih.gov/pubmed/23039216 http://dx.doi.org/10.1186/1475-2840-11-122

Ejemplares similares

Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients - an analysis of the DiaRegis registry
por: Tschöpe, Diethelm, et al.
Publicado: (2011)

Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registry
por: Wasem, Jürgen, et al.
Publicado: (2013)

Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry
por: Tschöpe, Diethelm, et al.
Publicado: (2012)

Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline
por: Bramlage, Peter, et al.
Publicado: (2010)

Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up
por: Bramlage, Peter, et al.
Publicado: (2014)

A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy
por: Gitt, Anselm K, et al.
Publicado: (2015)

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
por: Tschöpe, Diethelm, et al.
Publicado: (2013)

Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice – study rationale and protocol of DIALOGUE
por: Gitt, Anselm K, et al.
Publicado: (2012)

Individualised treatment targets in patients with type-2 diabetes and hypertension
por: Schmieder, Roland E., et al.
Publicado: (2018)

Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
por: Schmieder, Roland E, et al.
Publicado: (2015)

The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry
por: Tzamalis, Panagiotis, et al.
Publicado: (2019)

Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia
por: Eik, W., et al.
Publicado: (2016)

Professional Continuous Glucose Monitoring Reveals Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Treated with Oral Antidiabetics
por: Baretić, Maja, et al.
Publicado: (2021)

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study
por: Parhofer, Klaus G, et al.
Publicado: (2007)

Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine
por: Ott, Christian, et al.
Publicado: (2021)

Cardiovascular Safety of Oral Antidiabetic Medications: Need of the Hour
por: Kaduskar, Prashant Ulhas
Publicado: (2017)

Hypoglycemia in Patients With Diabetes on Antidiabetic Medications Who Fast for Laboratory Tests
por: Aldasouqi, Saleh, et al.
Publicado: (2011)

Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case–control analysis
por: Hsu, Chien-Yi, et al.
Publicado: (2016)

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis
por: Gautam, Santosh, et al.
Publicado: (2017)

Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia
por: Gitt, Anselm K., et al.
Publicado: (2022)

Hypoglycemia in Adults With Cystic Fibrosis During Oral Glucose Tolerance Testing
por: Hirsch, Irl B., et al.
Publicado: (2013)

The Detection of Postprandial Hypoglycemia with 5-Hour Oral Glucose Tolerance Test
por: Pant, Vivek, et al.
Publicado: (2021)

Predictive Low-Glucose Suspend Necessitates Less Carbohydrate Supplementation to Rescue Hypoglycemia: Need to Revisit Current Hypoglycemia Treatment Guidelines
por: Pinsker, Jordan E., et al.
Publicado: (2021)

Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2018)

Vascular Effects of Dietary Advanced Glycation End Products
por: Stirban, Alin, et al.
Publicado: (2015)

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)
por: Koska, Juraj, et al.
Publicado: (2021)

Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention: Structured intervention for community hypoglycemia
por: Pearson, Sam M., et al.
Publicado: (2021)

Oral Dextrose Gel Reduces the Need for Intravenous Dextrose Therapy in Neonatal Hypoglycemia
por: Rawat, Munmun, et al.
Publicado: (2016)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

Prognostic Relevance of Hypoglycemia Following an Oral Glucose Challenge for Cystic Fibrosis–Related Diabetes
por: Radike, Kerstin, et al.
Publicado: (2011)

Oral glucose gel in the prevention of neonatal hypoglycemia: A systematic review and meta-analysis
por: Wang, Meng-Qin, et al.
Publicado: (2023)

The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry
por: Agnelli, Giancarlo, et al.
Publicado: (2015)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs
por: Fritsche, Andreas, et al.
Publicado: (2019)

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
por: Bramlage, Peter, et al.
Publicado: (2015)

EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
por: Gitt, Anselm K, et al.
Publicado: (2013)

COVID-19-Pandemie: Effekte auf die klinische Versorgung von Herz-Kreislauf-Patienten im Frühling 2020
por: Zeymer, Uwe, et al.
Publicado: (2021)

Oral Glutamine Is Superior Than Oral Glucose to Promote Glycemia Recovery in Mice Submitted to Insulin-Induced Hypoglycemia
por: Nunes Santiago, Amanda, et al.
Publicado: (2013)

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
por: Fei, Yue, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7c0q8au10hok76ruc2krj6pdhh